A new multilevel PWM method: a theoretical analysis von Carrara, G., Gardella, S., Marchesoni, M., Salutari, R., Sciutto, G.

Volltext

Battery storage plant to improve energy saving and security of subway electric supply von Barcaglioni, M, Gaddi, F, Giglioli, R, Salutari, R, Saraceno, G.A, Zini, G

Volltext

Carboplatin-based doublet plus bevacizumab beyond progression versus carboplatin-based doublet alone in patients with platinum-sensitive ovarian cancer: a randomised, phase 3 trial von Pignata, Sandro, Lorusso, Domenica, Joly, Florence, Gallo, Ciro, Colombo, Nicoletta, Sessa, Cristiana, Bamias, Aristotelis, Salutari, Vanda, Selle, Frédèric, Frezzini, Simona, De Giorgi, Ugo, Pautier, Patricia, Bologna, Alessandra, Orditura, Michele, Dubot, Coraline, Gadducci, Angiolo, Mammoliti, Serafina, Ray-Coquard, Isabelle, Zafarana, Elena, Breda, Enrico, Favier, Laure, Ardizzoia, Antonio, Cinieri, Saverio, Largillier, Rémy, Sambataro, Daniela, Guardiola, Emmanuel, Lauria, Rossella, Pisano, Carmela, Raspagliesi, Francesco, Scambia, Giovanni, Daniele, Gennaro, Perrone, Francesco, Pignata, S, Lorusso, D, Joly, F, Gallo, C, Colombo, N, Sessa, C, Bamias, A, Salutari, V, Selle, F, Frezzini, S, De Giorgi, U, Pautier, P, Bologna, A, Orditura, M, Dubot, C, Gadducci, A, Mammoliti, S, Ray-Coquard, I, Zafarana, E, Breda, E, Favier, L, Ardizzoia, A, Cinieri, S, Largillier, R, Sambataro, D, Guardiola, E, Lauria, R, Pisano, C, Raspagliesi, F, Scambia, G, Daniele, G, Perrone, F

Volltext

Predictors of progression free survival, overall survival and early cessation of chemotherapy in women with potentially platinum sensitive (PPS) recurrent ovarian cancer (ROC) star... von Roncolato, F.T., O'Connell, R.L., Joly, F., Lanceley, A., Hilpert, F., Buizen, L., Okamoto, A., Aotani, E., Salutari, V., Donnellan, P., Oza, A., Avall-Lundqvist, E., Berek, J., Fehm, T., Ledermann, J., Roemer-Becuwe, C., Stockler, M.R., King, M.T., Friedlander, M.L.

Volltext

The Efficacy and Safety of Mirvetuximab Soravtansine in FRα-Positive, Third-Line and Later, Recurrent Platinum-Sensitive Ovarian Cancer: The Single-Arm Phase 2 PICCOLO Trial von Secord, A Alvarez, Lewin, S N, Murphy, C G, Cecere, S C, Barquín, A, Gálvez-Montosa, F, Mathews, C A, Konecny, G E, Ray-Coquard, I, Oaknin, A, Pérez, M J Rubio, Bonaventura, A, Diver, E J, Ayuk, S-A, Wang, Y, Corr, B R, Salutari, V

Volltext

The efficacy and safety of mirvetuximab soravtansine in FRα-positive, third-line and later, recurrent platinum-sensitive ovarian cancer: the single-arm phase II PICCOLO trial von Alvarez Secord, A, Lewin, S N, Murphy, C G, Cecere, S C, Barquín, A, Gálvez-Montosa, F, Mathews, C A, Konecny, G E, Ray-Coquard, I, Oaknin, A, Rubio Pérez, M J, Bonaventura, A, Diver, E J, Ayuk, S-M, Wang, Y, Corr, B R, Salutari, V

Volltext

MITO END-3: efficacy of avelumab immunotherapy according to molecular profiling in first-line endometrial cancer therapy von Pignata, S., Califano, D., Lorusso, D., Arenare, L., Bartoletti, M., De Giorgi, U., Andreetta, C., Pisano, C., Scambia, G., Lombardi, D., Farolfi, A., Cinieri, S., Passarelli, A., Salutari, V., De Angelis, C., Mignogna, C., Priolo, D., Capoluongo, E.D., Tamberi, S., Scaglione, G.L., Arcangeli, V., De Cecio, R., Scognamiglio, G., Greco, F., Spina, A., Turinetto, M., Russo, D., Carbone, V., Casartelli, C., Schettino, C., Perrone, F.

Volltext

Quality-of-life analysis of the MITO-8, MaNGO, BGOG-Ov1, AGO-Ovar2.16, ENGOT-Ov1, GCIG study comparing platinum-based versus non-platinum-based chemotherapy in patients with partia... von Piccirillo, M.C., Scambia, G., Bologna, A., Signoriello, S., Vergote, I., Baumann, K., Lorusso, D., Murgia, V., Sorio, R., Ferrandina, G., Sacco, C., Cormio, G., Breda, E., Cinieri, S., Natale, D., Mangili, G., Pisano, C., Cecere, S.C., Di Napoli, M., Salutari, V., Raspagliesi, F., Arenare, L., Bergamini, A., Bryce, J., Daniele, G., Gallo, C., Pignata, S., Perrone, F.

Volltext

Evaluation of the Practice of Antifungal Prophylaxis Use in Patients With Newly Diagnosed Acute Myeloid Leukemia: Results From the SEIFEM 2010-B Registry von Pagano, Livio, Caira, Morena, Candoni, Anna, Aversa, Franco, Castagnola, Carlo, Caramatti, Cecilia, Cattaneo, Chiara, Delia, Mario, De Paolis, Maria Rosaria, Di Blasi, Roberta, Di Caprio, Luigi, Fanci, Rosa, Garzia, Mariagrazia, Martino, Bruno, Melillo, Lorella, Mitra, Maria Enza, Nadali, Gianpaolo, Nosari, Annamaria, Picardi, Marco, Potenza, Leonardo, Salutari, Prassede, Trecarichi, Enrico Maria, Tumbarello, Mario, Verga, Luisa, Vianelli, Nicola, Busca, Alessandro

Volltext

Palbociclib plus letrozole in estrogen receptor-positive advanced/recurrent endometrial cancer: Double-blind placebo-controlled randomized phase II ENGOT-EN3/PALEO trial von Mirza, Mansoor R., Bjørge, Line, Marmé, Frederik, Christensen, René DePont, Gil-Martin, Marta, Auranen, Annika, Ataseven, Beyhan, Rubio, Maria Jesús, Salutari, Vanda, Luczak, Adam A., Runnebaum, Ingo B., Redondo, Andrés, Lindemann, Kristina, Trillsch, Fabian, Ginesta, M. Pilar Barretina, Roed, Henrik, Kurtz, Jean-Emmanuel, Petersson, Karen S., Nyvang, Gitte-Bettina, Sehouli, Jalid

Volltext

Therapeutic Potential of Tisotumab Vedotin in the Treatment of Recurrent or Metastatic Cervical Cancer: A Short Report on the Emerging Data von Agostinelli, Veronica, Musacchio, Lucia, Camarda, Floriana, Salutari, Vanda, Carbon, Maria Vittoria, Ghizzoni, Viola, Nero, Camilla, Ricci, Caterina, Perri, Maria Teresa, Giudice, Elena, Lardino, Sara, Berardi, Rossana, Scambia, Giovanni, Lorusso, Domenica

Volltext

751P Safety and tolerability of durvalumab (D) + carboplatin/paclitaxel (CP) + bevacizumab (B) followed by D, B + olaparib (O) maintenance (mtx) in patients (pts) with newly diagno... von Aghajanian, C., Schmalfeldt, B., Okamoto, A., Reuss, A., Kim, J-W., Marquina Ospina, G., Ayhan, A., Salutari, V., Lebreton, C., Labudovic, D., Tognon, G., Chudecka-Glaz, A.M., Berger, R., Lheureux, S., Henry, S., Burges, A., Wenham, R.M., Nishio, S., Marshall, L., Harter, P.

Volltext

LBA34 ENGOT-ov48/EUDARIO: European trial on enhanced DNA repair inhibition in ovarian cancer von Concin, N., Van Gorp, T., Lorusso, D., Ray-Coquard, I.L., Laenen, A., Zamagni, C., Harter, P., Sehouli, J., Raspagliesi, F., Zeimet, A.G., Lotz, J-P., Salutari, V., Tredan, O., Zeillinger, R., Dobbelstein, M., Moll, U., Kramer, D., Obermayr, E., Braicu, I., Vergote, I.B.

Volltext

Oxophilic Sn to Promote Glucose Oxidation to Formic Acid in Ni Nanoparticles von Montaña-Mora, Guillem, Mejia-Centeno, Karol V, Qi, Xueqiang, Xue, Qian, Chacón-Borrero, Jesus, Salutari, Francesco, Spadaro, Maria Chiara, Andreu, Teresa, Salazar-Alvarez, Germán, Güell, Frank, Llorca, Jordi, Arbiol, Jordi, Martinez-Alanis, Paulina R, Cabot, Andreu

Volltext

Nadroparin for the prevention of thromboembolic events in ambulatory patients with metastatic or locally advanced solid cancer receiving chemotherapy: a randomised, placebo-control... von Agnelli, Giancarlo, Prof, Gussoni, Gualberto, MD, Bianchini, Carlo, MD, Verso, Melina, MD, Mandalà, Mario, MD, Cavanna, Luigi, MD, Barni, Sandro, MD, Labianca, Roberto, MD, Buzzi, Franco, MD, Scambia, Giovanni, Prof, Passalacqua, Rodolfo, MD, Ricci, Sergio, MD, Gasparini, Giampietro, MD, Lorusso, Vito, Bonizzoni, Erminio, PhD, Tonato, Maurizio, MD

Volltext

Successful management of chronic disseminated candidiasis in hematologic patients treated with high-dose liposomal amphotericin B: a retrospective study of the SEIFEM registry von Della Pepa, Roberta, Picardi, M., Sorà, F., Stamouli, M., Busca, A., Candoni, A., Delia, M., Fanci, R., Perriello, V., Zancanella, M., Nosari, A., Salutari, P., Marchesi, F., Pane, F., Pagano, L.

Volltext

Systemic antifungal treatment after posaconazole prophylaxis: results from the SEIFEM 2010-C survey von Pagano, Livio, Verga, Luisa, Busca, Alessandro, Martino, Bruno, Mitra, Maria Enza, Fanci, Rosa, Ballanti, Stelvio, Picardi, Marco, Castagnola, Carlo, Cattaneo, Chiara, Nadali, Gianpaolo, Nosari, Annamaria, Candoni, Anna, Caira, Morena, Salutari, Prassede, Lessi, Federica, Aversa, Franco, Tumbarello, Mario

Volltext

Predictors of stopping chemotherapy early and short survival in patients with potentially platinum sensitive (PPS) recurrent ovarian cancer (ROC) who have had ≥3 lines of prior che... von Roncolato, Felicia, Joly, Florence, O'Connell, Rachel, Lanceley, Anne, Heitz, Florian, Buizen, Luke, Okamoto, Aikou, Aotani, Eriko, Salutari, Vanda, Donnellan, Paul P., Oza, Amit M., Avall-Lundqvist, Elisabeth, Berek, Jonathan S., Hilpert, Felix, Feeney, Amanda, Roemer-Becuwe, Celia, Stockler, Martin R., King, Madeleine Trudy, Friedlander, Michael

Volltext

Pre-chemotherapy risk factors for invasive fungal diseases: prospective analysis of 1,192 patients with newly diagnosed acute myeloid leukemia (SEIFEM 2010-a multicenter study) von Caira, Morena, Candoni, Anna, Verga, Luisa, Busca, Alessandro, Delia, Mario, Nosari, Annamaria, Caramatti, Cecilia, Castagnola, Carlo, Cattaneo, Chiara, Fanci, Rosa, Chierichini, Anna, Melillo, Lorella, Mitra, Maria Enza, Picardi, Marco, Potenza, Leonardo, Salutari, Prassede, Vianelli, Nicola, Facchini, Luca, Cesarini, Monica, De Paolis, Maria Rosaria, Di Blasi, Roberta, Farina, Francesca, Venditti, Adriano, Ferrari, Antonella, Garzia, Mariagrazia, Gasbarrino, Cristina, Invernizzi, Rosangela, Lessi, Federica, Manna, Annunziata, Martino, Bruno, Nadali, Gianpaolo, Offidani, Massimo, Paris, Laura, Pavone, Vincenzo, Rossi, Giuseppe, Spadea, Antonio, Specchia, Giorgina, Trecarichi, Enrico Maria, Vacca, Adriana, Cesaro, Simone, Perriello, Vincenzo, Aversa, Franco, Tumbarello, Mario, Pagano, Livio

Volltext

ENGOT-ov43/KEYLYNK-001: A phase III trial of pembrolizumab plus chemotherapy with olaparib maintenance for first-line treatment of BRCA¬-nonmutated advanced epithelial ovarian canc... von Fujiwara, K., Vergote, I.B., Sehouli, J., Salutari, V., Zola, P., Madry, R., Wenham, R.M., Korach, J., Pautier, P., Cibula, D., Lheureux, S., Hasegawa, K., Kim, B.-G., Lai, C.-H., Gonzalez-Martinez, A., Liu, Q., Keefe, S.M., Puglisi, M., Topuz, S.

Volltext